Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-06 21:03:48 UTC |
---|
Update Date | 2021-09-14 15:45:02 UTC |
---|
HMDB ID | HMDB0029130 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Valylisoleucine |
---|
Description | Valylisoleucine is a dipeptide composed of valine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. |
---|
Structure | CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O InChI=1S/C11H22N2O3/c1-5-7(4)9(11(15)16)13-10(14)8(12)6(2)3/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)/t7-,8-,9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
L-Val-L-ile | ChEBI | Valyl-isoleucine | ChEBI | VI | ChEBI | L-Valyl-L-isoleucine | HMDB | N-L-Valyl-L-isoleucine | HMDB | N-Valylisoleucine | HMDB | V-I dipeptide | HMDB | VI dipeptide | HMDB | Val-ile | HMDB | Valine isoleucine dipeptide | HMDB | Valine-isoleucine dipeptide | HMDB | Valylisoleucine | ChEBI |
|
---|
Chemical Formula | C11H22N2O3 |
---|
Average Molecular Weight | 230.308 |
---|
Monoisotopic Molecular Weight | 230.163042576 |
---|
IUPAC Name | (2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoic acid |
---|
Traditional Name | (2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoic acid |
---|
CAS Registry Number | 20556-14-3 |
---|
SMILES | CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O |
---|
InChI Identifier | InChI=1S/C11H22N2O3/c1-5-7(4)9(11(15)16)13-10(14)8(12)6(2)3/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)/t7-,8-,9-/m0/s1 |
---|
InChI Key | PNVLWFYAPWAQMU-CIUDSAMLSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Isoleucine or derivatives
- Valine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Fatty acid
- Amino acid or derivatives
- Carboxamide group
- Carboxylic acid salt
- Amino acid
- Secondary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic salt
- Hydrocarbon derivative
- Amine
- Primary aliphatic amine
- Organic oxide
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Organic zwitterion
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -1.16 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 163.819 | 30932474 | DeepCCS | [M-H]- | 161.424 | 30932474 | DeepCCS | [M-2H]- | 194.308 | 30932474 | DeepCCS | [M+Na]+ | 169.732 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Valylisoleucine,1TMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C | 1797.7 | Semi standard non polar | 33892256 | Valylisoleucine,1TMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O | 1831.3 | Semi standard non polar | 33892256 | Valylisoleucine,1TMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 1778.8 | Semi standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C | 1878.9 | Semi standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C | 1846.8 | Standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 1791.2 | Semi standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 1887.2 | Standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 1826.6 | Semi standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 1851.5 | Standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #4 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1989.3 | Semi standard non polar | 33892256 | Valylisoleucine,2TMS,isomer #4 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1882.3 | Standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 1860.0 | Semi standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 1910.7 | Standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2001.5 | Semi standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1983.8 | Standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1981.5 | Semi standard non polar | 33892256 | Valylisoleucine,3TMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1999.3 | Standard non polar | 33892256 | Valylisoleucine,4TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2045.0 | Semi standard non polar | 33892256 | Valylisoleucine,4TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2070.8 | Standard non polar | 33892256 | Valylisoleucine,1TBDMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2030.6 | Semi standard non polar | 33892256 | Valylisoleucine,1TBDMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O | 2056.1 | Semi standard non polar | 33892256 | Valylisoleucine,1TBDMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 1997.7 | Semi standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2299.8 | Semi standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #1 | CC[C@H](C)[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2235.3 | Standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 2239.6 | Semi standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 2285.5 | Standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2282.0 | Semi standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2216.7 | Standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #4 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2429.2 | Semi standard non polar | 33892256 | Valylisoleucine,2TBDMS,isomer #4 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2250.5 | Standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2511.5 | Semi standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2470.7 | Standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2665.6 | Semi standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #2 | CC[C@H](C)[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2512.8 | Standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2638.9 | Semi standard non polar | 33892256 | Valylisoleucine,3TBDMS,isomer #3 | CC[C@H](C)[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2520.5 | Standard non polar | 33892256 | Valylisoleucine,4TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2918.5 | Semi standard non polar | 33892256 | Valylisoleucine,4TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2766.8 | Standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Valylisoleucine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valylisoleucine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 10V, Negative-QTOF | splash10-01t9-1390000000-87b5ab626478a3044f09 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 20V, Negative-QTOF | splash10-001i-3900000000-df806cf0623e50b445e2 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 40V, Negative-QTOF | splash10-0a5a-9000000000-5d15054d956d795731fa | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 10V, Positive-QTOF | splash10-001i-2290000000-4a772e20afbb492b0e7e | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 20V, Positive-QTOF | splash10-00di-9510000000-15d5864f038f0338f47e | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylisoleucine 40V, Positive-QTOF | splash10-0a4i-9000000000-4f56d925b7943c3ee65f | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB112132 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5374098 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 7010531 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 75012 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Yang S, Jia C, Zhu H, Han S: CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis. Tumour Biol. 2012 Dec;33(6):2265-72. doi: 10.1007/s13277-012-0488-y. Epub 2012 Sep 5. [PubMed:22948778 ]
- Yeaman SJ, Cohen P, Watson DC, Dixon GH: The substrate specificity of adenosine 3':5'-cyclic monophosphate-dependent protein kinase of rabbit skeletal muscle. Biochem J. 1977 Feb 15;162(2):411-21. [PubMed:192223 ]
- Hirsch-Behnam A, Delius H, de Villiers EM: A comparative sequence analysis of two human papillomavirus (HPV) types 2a and 57. Virus Res. 1990 Dec;18(1):81-97. [PubMed:1964523 ]
|
---|